Skip to main content
Mark A. Fisher
No Rating Available
(Learn About Our Rating System)

Mark A. Fisher, PhD

Languages spoken: English
  • Dr. Fisher is the medical director of the Bacteriology, Antimicrobials, Parasitology, and Infectious Disease Rapid Testing laboratories at ARUP and an assistant professor of pathology at the University of Utah School of Medicine. He is board certified in medical microbiology, and his research interests include microbial pathogenesis and transmission of vector borne pathogens.

    Specialties

    • Clinical Microbiology

    Board Certification

    American Board of Medical Microbiology
  • Dr. Fisher is the medical director of the Bacteriology, Antimicrobials, Parasitology, and Infectious Disease Rapid Testing laboratories at ARUP and an assistant professor of pathology at the University of Utah School of Medicine. He is board certified in medical microbiology, and his research interests include microbial pathogenesis and transmission of vector borne pathogens.

    Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Board Certification
    American Board of Medical Microbiology

    Education history

    Fellowship Medical Microbiology, ABMM - University of Utah School of Medicine, Department of Pathology Clinical Fellow
    Microbial Genetics and Pathogenesis - Rocky Mountain Laboratories. Laboratory of Zoonotic Pathogens, NIAID, NIH Postdoctoral Fellow
    Doctoral Training Microbiology and Molecular Genetics - Emory University Ph.D.
    Microbiology - Idaho State University M.S.
    Undergraduate Microbiology, High Honors - Idaho State University B.S.
    Undergraduate Pharmacy - Boise State University Pre Pharmacy

    Selected Publications

    Journal Article

    1. Rubio J, Yan J, Miller S, Cheng J, Li R, Builta Z, Aoyagi K, Fisher M, She R, Spellberg B, Luna B (Accepted for publication 8/11/24). Polymyxins retain in vitro activity and in vivo efficacy against “resistant” Acinetobacter baumannii strains when tested in physiological conditions. (Epub ahead of print) Antimicrob Agents Chemother.
    2. Pham J, Benefield RJ, Baker N, Lindblom S, Canfield N, Gomez CA, Fisher M (2024). In vitro activity of omadacycline against clinical isolates of Nocardia. Antimicrob Agents Chemother, 68(5), e0168623. (Read full article)
    3. Andrews SR, Timbrook TT, Fisher MA, Tritle BJ (2023). Comparative analysis of a rapid diagnostic test and scoring tools for ESBL detection in Enterobacterales bloodstream infections for optimizing antimicrobial therapy. Microbiol Spectr, 12(1), e0313123. (Read full article)
    4. Lim AL, Miller BW, Lin Z, Fisher MA, Barrows LR, Haygood MG, Schmidt EW (2023). Resistance mechanisms for Gram-negative bacteria-specific lipopeptides, turnercyclamycins, differ from that of colistin. Microbiol Spectr, 11(6), e0230623. (Read full article)
    5. Brown DG, Wahlig TA, Ma A, Certain LK, Chalmers PN, Fisher MA, Leung DT (2023). Genomic Characterization of 2 Cutibacterium acnes Isolates from a Surgical Site Infection Reveals Large Genomic Inversion. Pathog Immun, 8(1), 64-76. (Read full article)
    6. Mathew B, Aoyagi KL, Fisher MA (2023). Antibacterial activity of Xenopsylla cheopis attacins against Yersinia pestis. bioRxiv, 08.26.554949.
    7. Aoyagi KL, Mathew B, Fisher MA (2023). Enterobacterial common antigen biosynthesis in Yersinia pestis is tied to antimicrobial peptide resistance. bioRxiv, 08.26.554945. (Read full article)
    8. Walker BS, Schmidt RL, Moore RA, White SK, Fisher MA, Metcalf RA (2022). Bacterial culture time to detection in platelet components: An evidence synthesis and estimation of detection failures. Transfusion, 63(1), 182-192. (Read full article)
    9. Liu BM, Beck EM, Fisher MA (2021). The Brief Case: Ventilator-Associated Corynebacterium accolens Pneumonia in a Patient with Respiratory Failure Due to COVID-19. J Clin Microbiol, 59(9), e0013721. (Read full article)
    10. Mathew B, Aoyagi KL, Fisher MA (2021). Yersinia pestis Lipopolysaccharide Remodeling Confers Resistance to a Xenopsylla cheopis Cecropin. **Included in the Special Issue "Antibiotic Alternatives."**. ACS Infect Dis, 7(8), 2536-2545. (Read full article)
    11. Liu BM, Carlisle CP, Fisher MA, Shakir SM (2021). The Brief Case: Capnocytophaga sputigena Bacteremia in a 94-Year-Old Male with Type 2 Diabetes Mellitus, Pancytopenia, and Bronchopneumonia. J Clin Microbiol, 59(7), e0247220. (Read full article)
    12. Miller BW, Lim AL, Lin Z, Bailey J, Aoyagi KL, Fisher MA, Barrows LR, Manoil C, Schmidt EW, Haygood MG (2021). Shipworm symbiosis ecology-guided discovery of an antibiotic that kills colistin-resistant Acinetobacter. Cell Chem Biol, 28, 1628-1637.e4. (Read full article)
    13. Corean J, White SK, Schmidt RL, Walker BS, Fisher MA, Metcalf RA (2021). Platelet Component False Positive Detection Rate in Aerobic and Anaerobic Primary Culture: A Systematic Review and Meta-Analysis. Transfus Med Rev, 35(3), 44-52. (Read full article)
    14. Corean J, White SK, Schmidt RL, Walker BS, Fisher MA, Metcalf RA (2020). The incremental benefit of anaerobic culture for controlling bacterial risk in platelets: a systematic review and meta-analysis. Vox Sang, 116(4), 397-404. (Read full article)
    15. Shakir SM, Gill R, Salberg J, Slechta ES, Feldman M, Fritsche T, Clarridge J, Sharp SE, Fisher MA (2021). Clinical Laboratory Perspective on Streptococcus halichoeri, an Unusual Nonhemolytic, Lancefield Group B Streptococcus Causing Human Infections. Emerg Infect Dis, 27(5), 1309-1316.
    16. Peterson JA, Fisher MA, Lacy MD (2020). Bordetella holmesii Bacteremia and Cellulitis in an Immunocompetent Patient. Infect Dis Clin Pract (Baltim Md), 28(5), 308-310.
    17. Walker BS, Schmidt RL, Fisher MA, White SK, Blaylock RC, Metcalf RA (2020). The comparative safety of bacterial risk control strategies for platelet components: a simulation study. Transfusion, 60(8), 1723-1731. (Read full article)
    18. Rossi A, Fisher MA (2020). Characterization of six clinical isolates of Chimaeribacter gen. nov., a novel genus related to the Yersiniaceae family and the three species Chimaeribacter arupi sp. nov., Chimaeribacter coloradensis sp. nov, and Chimaeribacter californicus sp. nov. Int J Syst Evol Microbiol, 70(4), 2703-2712. (Read full article)
    19. Forde BM, Roberts LW, Phan MD, Peters KM, Fleming BA, Russell CW, Lenherr SM, Myers JB, Barker AP, Fisher MA, Chong TM, Yin WF, Chan KG, Schembri MA, Mulvey MA, Beatson SA (2019). Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection. Nat Commun, 10(1), 3643. (Read full article)
    20. Lacy MD and Fisher MA (2019). Sepsis, Helicoid Bacteremia, and Pneumatosis Intestinalis. Infect Dis Clin Pract (Baltim Md), 27(5), 292-294.
    21. Langelier C, Graves M, Kalantar K, Caldera S, Durrant R, Fisher MA, Backman R, Tanner W, DeRisi JL, Leung DT (2019). Microbiome and Antimicrobial Resistance Gene Dynamics in International Travelers. Emerg Infect Dis, 25(7), 1380-1383.
    22. Tanner WD, VanDerslice JA, Goel RK, Leecaster MK, Fisher MA, Olstadt J, Gurley CM, Morris AG, Seely KA, Chapman L, Korando M, Shabazz KA, Stadsholt A, VanDeVelde J, Braun-Howland E, Minihane C, Higgins PJ, Deras M, Jaber O, Jette D, Gundlapalli AV (2019). Multi-state study of Enterobacteriaceae harboring extended-spectrum beta-lactamase and carbapenemase genes in U.S. drinking water. Sci Rep, 9(1), 3938. (Read full article)
    23. Shakir SM, Powers-Fletcher MV, Slechta ES, Fisher MA (2017). Helicobacter canis bacteraemia and cellulitis in a patient with end-stage renal disease. JMM Case Rep, 4(11), e005126.
    24. Prasidthrathsint K, Fisher MA (2017). Antimicrobial Susceptibility Patterns among a Large, Nationwide Cohort of Abiotrophia and Granulicatella Clinical Isolates. J Clin Microbiol, 55(4), 1025-1031. (Read full article)
    25. Summers SJ, Patel DP, Hamilton BD, Presson AP, Fisher MA, Lowrance WT, Southwick AW (2015). An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy. World J Urol, 33(12), 2001-7. (Read full article)
    26. de Dios A, Jacob S, Tayal A, Fisher MA, Dingle TC, Hamula CL (2015). First Report of Wohlfahrtiimonas chitiniclastica Isolation from a Patient with Cellulitis in the United States. J Clin Microbiol, 53(12), 3942-4. (Read full article)
    27. Khot PD, Bird BA, Durrant RJ, Fisher MA (2015). Identification of Nocardia Species by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. J Clin Microbiol, 53(10), 3366-9. (Read full article)
    28. Chari A, Oakeson KF, Enomoto S, Jackson DG, Fisher MA, Dale C (2015). Phenotypic characterization of Sodalis praecaptivus sp. nov., a close non-insect-associated member of the Sodalis-allied lineage of insect endosymbionts. Int J Syst Evol Microbiol, 65(Pt 5), 1400-1405. (Read full article)
    29. Pusch T, Fisher MA, Gander RM (2015). Cardiobacterium valvarum, an Emerging New HACEK Organism, as the Causative Agent of Infective Endocarditis: Case Report and Review of the Literature. Clin Microbiol Newsl, 37(16), 127-32.
    30. Aoyagi KL, Brooks BD, Bearden SW, Montenieri JA, Gage KL, Fisher MA (2014). LPS modification promotes maintenance of Yersinia pestis in fleas. Microbiology (Reading), 161(Pt 3), 628-38. (Read full article)
    31. Schlaberg R, Fisher MA, Hanson KE (2013). Susceptibility profiles of Nocardia isolates based on current taxonomy. Antimicrob Agents Chemother, 58(2), 795-800. (Read full article)
    32. Brooks AE, Brooks BD, Davidoff SN, Hogrebe PC, Fisher MA, Grainger DW (2015). Polymer-controlled release of tobramycin from bone graft void filler. Drug Deliv Transl Res, 3(6), 518-30. (Read full article)
    33. Schlaberg R, Fisher MA, Hanson KE (2014). Susceptibility Profiles of Nocardia Isolates Based on Current Taxonomy. Antimicrob Agents Chemother, 58(2), 795-800.
    34. Khot PD, Fisher MA (2013). Novel approach for differentiating Shigella species and Escherichia coli by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol, 51(11), 3711-6. (Read full article)
    35. Khot PD, Fisher MA (2013). Novel Approach for Differentiating Shigella Species and Escherichia coli by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry. J Clin Microbiol, 51(11), 3711-6.
    36. Couturier BA, Couturier MR, Kalp KJ, Fisher MA (2013). Detection of non-jejuni and -coli Campylobacter species from stool specimens with an immunochromatographic antigen detection assay. J Clin Microbiol, 51(6), 1935-7. (Read full article)
    37. Couturier BA, Couturier MR, Kalp KJ, Fisher MA (2013). Detection of non-jejuni and -coli Campylobacter Species from Stool Specimens with an Immunochromatographic Antigen Detection Assay. J Clin Microbiol, 51(6), 1935-7.
    38. Wolfgang WJ, Passaretti TV, Jose R, Cole J, Coorevits A, Carpenter AN, Jose S, Van Landschoot A, Izard J, Kohlerschmidt DJ, Vandamme P, Dewhirst FE, Fisher MA, Musser KA (2012). Neisseria oralis sp. nov., isolated from healthy gingival plaque and clinical samples. Int J Syst Evol Microbiol, 63(Pt 4), 1323-1328. (Read full article)
    39. Khot PD, Couturier MR, Wilson A, Croft A, Fisher MA (2012). Optimization of matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis for bacterial identification. J Clin Microbiol, 50(12), 3845-52. (Read full article)
    40. Blaschke AJ, Heyrend C, Byington CL, Fisher MA, Barker E, Garrone NF, Thatcher SA, Pavia AT, Barney T, Alger GD, Daly JA, Ririe KM, Ota I, Poritz MA (2012). Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis, 74(4), 349-55. (Read full article)
    41. Stallworth C, Steed L, Fisher MA, Nolte FS (2012). Legionnaires' disease caused by Legionella londiniensis. J Clin Microbiol, 50(12), 4178-9. (Read full article)
    42. Clayton AL, Oakeson KF, Gutin M, Pontes A, Dunn DM, von Niederhausern AC, Weiss RB, Fisher MA, and Dale C (2012). A Novel Human-Infection Derived Bacterium Provides Insights into the Evolutionary Origins of Mutualistic Insect-Bacterial Symbioses. **Recommended article, Faculty of 1000, Feb, 2013**. PLoS Genet, 8(11), e1002990.
    43. Stallworth C, Steed L, Fisher MA, Nolte FS (2012). A Case of Legionnaires' Disease Caused by Legionella londiniensis. J Clin Microbiol, 50(12), 4178-9.
    44. Barker AP, Simmon KE, Cohen S, Slechta ES, Fisher MA, Schlaberg R (2012). Isolation and identification of Kroppenstedtia eburnea isolates from multiple patient samples. J Clin Microbiol, 50(10), 3391-4. (Read full article)
    45. Khot PD, Couturier MR, Wilson A, Croft A, Fisher MA (2012). Optimization of MALDI-TOF Mass Spectrometry Analysis for Bacterial Identification. J Clin Microbiol, 50(12), 3845-52.
    46. Couturier MR, Slechta ES, Goulston C, Fisher MA, Hanson KE (2012). Leptotrichia bacteremia in patients receiving high-dose chemotherapy. J Clin Microbiol, 50(4), 1228-32. (Read full article)
    47. Schlaberg R, Simmon KE, Fisher MA (2012). A systematic approach for discovering novel, clinically relevant bacteria. Emerg Infect Dis, 18(3), 422-30. (Read full article)
    48. Kallstrom G, Chang T, Albertson M, Morilla D, Fisher MA, Eberly B (2011). Recovery of a catalase-negative Staphylococcus epidermidis strain in blood and urine cultures from a patient with pyelonephritis. J Clin Microbiol, 49(11), 4018-9. (Read full article)
    49. Simmon KE, Fang DC, Tesic V, Khot PD, Giangeruso E, Bolesta ES, Wagner-Reiss KM, Fisher MA, Petti CA, Han XY, She RC (2011). Isolation and characterization of "Pseudomonas andersonii" from four cases of pulmonary granulomas and emended species description. J Clin Microbiol, 49(4), 1518-23. (Read full article)
    50. Couturier MR, Mehinovic E, Croft AC, Fisher MA (2011). Identification of HACEK clinical isolates by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol, 49(3), 1104-6. (Read full article)
    51. Iroh Tam PY, Fisher MA, Miller NS (2010). Corynebacterium falsenii bacteremia occurring in an infant on vancomycin therapy. J Clin Microbiol, 48(9), 3440-2. (Read full article)
    52. Fisher MA, Stamper PD, Hujer KM, Love Z, Croft A, Cohen S, Bonomo RA, Carroll KC, Petti CA (2009). Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum beta-lactamase, AmpC and KPC producers. J Med Microbiol, 58(Pt 6), 774-778. (Read full article)
    53. Fisher MA, Grimm D, Henion AK, Elias AF, Stewart PE, Rosa PA, Gherardini FC (2005). From the cover: Borrelia burgdorferi σ54 is Required for Mammalian Infection and Vector Transmission but not for Tick Colonization. **Commentary on p. 4933-4**. Proc Natl Acad Sci U S A, 102(14), 5162-7. (Read full article)

    Book Chapter

    1. Fisher MA, Shakir SM, Lopansri BK (in press). Molecular Methods for Epidemiological Typing of Microorganisms. In Leber AL, Burnham CAB (Eds.), Clinical Microbiology Procedures Handbook (5th Edition). Washington, DC: ASM Press.
    2. Fisher MA, Powers-Fletcher M (2022). MALDI-TOF for Bacterial and Yeast Identification. In Leber AL, Burnham CAB (Eds.), Clinical Microbiology Procedures Handbook (5th Edition). Washington, DC: ASM Press.
    3. Fisher MA (2017). Differentiation of closely related organisms using MALDI-TOF MS. In Shah HN, Gharbia SE (Eds.), MALDI-TOF and Tandem MS for Clinical Microbiology (pp. 147-165). West Sussex, UK: Wiley.
    4. Lopansri B, Fisher MA (2016). Molecular Methods for Epidemiologic Typing of Microorganisms. In Leber, Amy L (Eds.), Clinical Microbiology Procedures Handbook (4th, 3, pp. 12.4.2.1-12.4.2.20). Washington, DC: American Society for Microbiology.

    Letter

    1. Babady NE, Bourassa L, Burnham CD, Fisher M, McElvania E, Polage CR, Ribes J (2021). Multicenter Evaluation of Processing and Analysis of College of American Pathologists (CAP) Proficiency Testing Samples by Laboratory Automation. [Letter to the editor]. J Clin Microbiol, 59(5), e03233-20. (Read full article)
    2. Tritle BJ, Timbrook TT, Fisher MA, Spivak ES (2019). Penicillin as a Potential Agent for Dual β-Lactam Therapy for Enterococcal Endocarditis. [Letter to the editor]. Clin Infect Dis, 70(6), 1263-1264. (Read full article)
    3. Bagdure SR, Fisher MA, Ryan ME, Khasawneh FA (2012). Rhodococcus erythropolis encephalitis in patient receiving rituximab. [Letter to the editor]. Emerg Infect Dis, 18(8), 1377-9. (Read full article)

    Abstract

    1. Liu BM, Simmon K, Fisher MA (2021). Phenotypic and Genomic Analysis of Novel, Fastidious, Gram-negative Bacilli Isolated from Clinical Wound Specimens [Abstract]. 8(Sup 1), S424-S424.

    Video/Film/CD/Web/Podcast

    1. Milner D, Swails K, Buss S, Culbreath K, Fisher MA, McElvania E (2021). Guest Panelist for the American Society for Clinical Pathology In The Lab podcast "Consolidation and Total Laboratory Automation." Downloaded >1350 times from ≥52 countries and >1850 CE credits awarded in the first 6 months. Oct. 12, 2021 [Podcast]. Season 2, Episode 5: American Society for Clinical Pathology. Available: https://www.ascp.org/content/learning/inside-the-lab#.
    2. Fisher MA (2021). ASM Clinical Microbiology Virtual Journal Club presentation of "Evaluation of the WASPLab segregation software to automatically analyze urine cultures using routine blood and MacConkey agars." ** #3 most liked session in 2021. ** Feb 9, 2021 [Video]. American Society for Microbiology. Available: https://asm.org/Webinars/Virtual-Journal-Club.
    3. Fisher MA (2019). Rapid Antimicrobial Susceptibility Testing. ≥6423 viewers, 3963 CE credits awarded in 2 yrs. ** #4 most liked (#2 among those given by an ARUP Medical Director) ARUP Institute for Learning Webinar, FY2020 **. Dec 10, 2019 [Video]. Salt Lake City, UT: ARUP Laboratories. Available: https://arup.utah.edu/education/fisher-rapidAST-2019.php?_ga=2.92789150.2058032789.1650834656-1381250972.1650834656.
    4. Khot PD, Fisher MA (2011). Bacterial Identification by Mass Spectrometry. ARUP Institute For Learning Webinar. ≥1071 views, ≥448 CE credits awarded. June 29, 2011 [Video]. Salt Lake City, UT: ARUP Laboratories. Available: https://arup.utah.edu/education/mass_spec.php?_ga=2.99950237.2058032789.1650834656-1381250972.1650834656.